# ETRAVIRINE
> **ANDA215402** · Abbreviated New Drug Application (Generic) · Sponsor: CARNEGIE · Approved 2022-04-13
## Drug
- **FDA Application Number:** ANDA215402
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ETRAVIRINE
- **Generic name:** ETRAVIRINE
- **Active ingredients:** ETRAVIRINE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** CARNEGIE
- **Manufacturer:** Carnegie Pharmaceuticals LLC
- **First approval:** 2022-04-13
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215402)
---
*MORVS · CC0 1.0*